Comparison of pathological alterations in ALS and a murine transgenic model: pathogenetic implications.
The first part of this paper summarizes the main pathological features of sporadic amyotrophic lateral sclerosis (ALS) and familial amyotrophic lateral sclerosis (FALS). In both diseases, the primary lesion consists of degeneration of both upper and lower motor neurons, resulting in severe neuronal loss, particularly in the spinal cord. An important difference between sporadic ALS and FALS is in the involvement of sensory and spinocerebellar projections in the latter. The second part of the paper will compare the familial form of ALS with its recently described transgenic murine model. The production of this model followed the discovery that FALS is tightly linked to several different mutations in the enzyme Cu,Zn superoxide dismutase (SOD), a ubiquitous enzyme involved in the dismutation of superoxide anion to hydrogen peroxide. A human transgene with one of the identified mutations was expressed in mice, and the resulting progeny developed clinical and pathological changes that, in the late stages of disease, were very similar to those in patients with FALS. There was, in fact, exquisite degeneration of motor neurons in spinal cord and brain stem, as well as degeneration of white matter tracts of the spinal cord, of the anterior roots and neurogenic atrophy of skeletal muscles, as described in patients with FALS. Beckman and colleagues postulated that mutations in SOD may alter the structure of the copper active site with resultant decrease in superoxide anion dysmutation while favoring an increase in reactivity with other radicals such as peroxynitrite. The formation of nitronium-like intermediate could damage proteins, particularly by nitration of tyrosine residues. Nitration of tyrosine kinases and altered phosphorilation of neurofilaments could be particularly damaging for motor neurons.
Dal Canto
M C
MC
Northwestern University Medical School, Chicago, IL, USA.
D000690:Amyotrophic Lateral Sclerosis / Q000473:pathology*; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic